Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

BMJ. 1998 Jul 11;317(7151):119-20. doi: 10.1136/bmj.317.7151.119.

Authors

R M Martin¹, K V Kapoor, L V Wilton, R D Mann

Affiliation

¹ Drug Safety Research Unit, Southampton SO31 1AA.

No abstract available

MeSH terms

Adverse Drug Reaction Reporting Systems / statistics & numerical data*
Drug-Related Side Effects and Adverse Reactions*
Family Practice / statistics & numerical data*
Forms and Records Control
Humans
Professional Practice
United Kingdom